- Home
- ELDN vs OWLT Comparison
ELDN vs OWLT Comparison
Compare ELDN & OWLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- OWLT
- Stock Information
- Founded
- ELDN 2004
- OWLT 2013
- Country
- ELDN United States
- OWLT United States
- Employees
- ELDN N/A
- OWLT N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- OWLT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ELDN Health Care
- OWLT Health Care
- Exchange
- ELDN Nasdaq
- OWLT Nasdaq
- Market Cap
- ELDN 164.1M
- OWLT 148.6M
- IPO Year
- ELDN N/A
- OWLT N/A
- Fundamental
- Price
- ELDN $3.50
- OWLT $8.56
- Analyst Decision
- ELDN Strong Buy
- OWLT
- Analyst Count
- ELDN 2
- OWLT 0
- Target Price
- ELDN $12.50
- OWLT N/A
- AVG Volume (30 Days)
- ELDN 1.4M
- OWLT 64.8K
- Earning Date
- ELDN 11-11-2025
- OWLT 11-12-2025
- Dividend Yield
- ELDN N/A
- OWLT N/A
- EPS Growth
- ELDN N/A
- OWLT N/A
- EPS
- ELDN 0.21
- OWLT N/A
- Revenue
- ELDN N/A
- OWLT $89,774,000.00
- Revenue This Year
- ELDN N/A
- OWLT $28.93
- Revenue Next Year
- ELDN N/A
- OWLT $22.82
- P/E Ratio
- ELDN $16.22
- OWLT N/A
- Revenue Growth
- ELDN N/A
- OWLT 36.78
- 52 Week Low
- ELDN $2.32
- OWLT $2.75
- 52 Week High
- ELDN $5.54
- OWLT $10.30
- Technical
- Relative Strength Index (RSI)
- ELDN 70.99
- OWLT 49.07
- Support Level
- ELDN $2.58
- OWLT $8.39
- Resistance Level
- ELDN $2.71
- OWLT $9.25
- Average True Range (ATR)
- ELDN 0.24
- OWLT 0.53
- MACD
- ELDN 0.07
- OWLT -0.07
- Stochastic Oscillator
- ELDN 72.69
- OWLT 32.26
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About OWLT Owlet Inc.
Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.